Twin Capital Management Inc Incyte Corp Call Options Transaction History
Twin Capital Management Inc
- $787 Million
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding INCY
# of Institutions
625Shares Held
216MCall Options Held
366KPut Options Held
445K-
Baker Bros. Advisors LP New York, NY36.2MShares$2.48 Billion26.1% of portfolio
-
Black Rock Inc. New York, NY23.2MShares$1.59 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$1.56 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA15.4MShares$1.06 Billion0.54% of portfolio
-
State Street Corp Boston, MA9.9MShares$679 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $15.3B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...